0R15 9025.0 0.0% 0R1E 9410.0 0.0% 0M69 None None% 0R2V 247.99 9682.643% 0QYR 1567.5 0.0% 0QYP 439.3701 -2.9016% 0RUK None None% 0RYA 1597.0 1.2682% 0RIH 195.55 0.0% 0RIH 191.4 -2.1222% 0R1O 225.5 9683.0803% 0R1O None None% 0QFP 10475.8496 107.8542% 0M2Z 252.573 0.2373% 0VSO 33.0 -7.3164% 0R1I None None% 0QZI 622.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 222.05 -4.1318%
Last update at 2024-12-19T18:48:00Z
Afya Limited's (NASDAQ:AFYA) Intrinsic Value Is Potentially 98% Above Its Share Price
Fri 18 Oct 24, 11:20 AMIs the Options Market Predicting a Spike in AFYA Stock?
Fri 27 Sep 24, 02:43 PMAfya Limited to Host Afya Day 2024 on October 29th | Hybrid Event
Fri 27 Sep 24, 12:41 PMIs Now An Opportune Moment To Examine Afya Limited (NASDAQ:AFYA)?
Mon 02 Sep 24, 06:40 PMAfya Secures Full Disbursement of R$500 Million From IFC to Support the Company’s Expansion
Fri 30 Aug 24, 08:42 PMAfya Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Sat 17 Aug 24, 01:33 PMTop 3 Growth Stocks With Insider Ownership Expecting Up To 40% Earnings Growth
Thu 15 Aug 24, 09:31 PMAfya (AFYA) Surpasses Q2 Earnings and Revenue Estimates
Thu 15 Aug 24, 02:45 PMAfya Limited Announces Second-Quarter and First-Half 2024 Financial Results
Thu 15 Aug 24, 01:27 PMUS Growth Companies With High Insider Ownership
Tue 13 Aug 24, 11:03 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 428.43M | 273.46M | 335.05M | 186.94M | 98.72M |
| Minority interest | -19.18700M | -18.95700M | 51.56M | 48.63M | 88.37M |
| Net income | 373.57M | 223.33M | 292.07M | 153.92M | 86.35M |
| Selling general administrative | 798.15M | 622.62M | 402.86M | 239.12M | 70.03M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 1469.51M | 1067.07M | 766.54M | 441.78M | 165.88M |
| Reconciled depreciation | 206.22M | 154.22M | 108.74M | 73.15M | 9.08M |
| Ebit | 664.10M | 440.89M | 363.33M | 205.25M | 97.92M |
| Ebitda | 856.35M | 585.53M | 542.07M | 278.05M | 107.00M |
| Depreciation and amortization | 192.25M | 144.64M | 178.73M | 72.80M | 9.08M |
| Non operating income net other | - | - | - | 0.00000M | 0.00000M |
| Operating income | 664.10M | 440.89M | 363.33M | 205.25M | 96.45M |
| Other operating expenses | 1665.13M | 1281.78M | 837.86M | 552.18M | 237.49M |
| Interest expense | 288.65M | 175.65M | 98.27M | 55.47M | 2.40M |
| Tax provision | 35.68M | 31.18M | 27.07M | 14.18M | 3.99M |
| Interest income | 27.20M | 23.04M | 62.29M | 9.68M | 4.36M |
| Net interest income | -314.63100M | -193.72400M | -35.97900M | -51.38100M | -0.92800M |
| Extraordinary items | - | - | - | 0.00000M | 0.00000M |
| Non recurring | - | - | - | 0.00000M | 0.00000M |
| Other items | - | - | - | 0.00000M | 0.00000M |
| Income tax expense | 35.68M | 31.18M | 27.07M | 14.18M | 3.99M |
| Total revenue | 2329.06M | 1719.37M | 1201.19M | 750.63M | 333.94M |
| Total operating expenses | 805.58M | 629.48M | 403.20M | 243.33M | 69.44M |
| Cost of revenue | 859.55M | 652.30M | 434.65M | 308.85M | 168.05M |
| Total other income expense net | -235.66700M | -167.43300M | -28.28100M | -18.31400M | 3.20M |
| Discontinued operations | - | - | - | 0.00000M | 0.00000M |
| Net income from continuing ops | 392.76M | 242.28M | 307.99M | 172.76M | 94.73M |
| Net income applicable to common shares | 373.57M | 223.33M | 292.07M | 153.92M | 86.35M |
| Preferred stock and other adjustments | - | - | - | 0.00000M | 0.00000M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 7584.48M | 7199.54M | 6447.41M | 4793.09M | 2912.45M |
| Intangible assets | 3461.32M | 2784.45M | 2716.50M | 1762.35M | 852.93M |
| Earning assets | - | - | - | - | - |
| Other current assets | 58.91M | 51.74M | 42.53M | 29.61M | 17.91M |
| Total liab | 3941.47M | 3949.38M | 3447.39M | 1959.31M | 798.73M |
| Total stockholder equity | 3601.51M | 3198.84M | 2948.15M | 2782.22M | 2065.09M |
| Deferred long term liab | - | - | - | - | 0.00000M |
| Other current liab | 226.71M | 199.61M | 184.82M | 121.74M | 70.56M |
| Common stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Capital stock | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M |
| Retained earnings | 1380.37M | 1004.89M | 631.32M | 407.99M | 134.03M |
| Other liab | - | 568.93M | 687.35M | 408.21M | 196.93M |
| Good will | 1334.70M | 1257.05M | 1184.34M | 810.66M | 459.41M |
| Other assets | - | 234.32M | 207.75M | 83.72M | 29.12M |
| Cash | 553.03M | 1093.08M | 748.56M | 1045.04M | 943.21M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1058.57M | 905.69M | 766.51M | 589.38M | 333.23M |
| Current deferred revenue | 153.49M | 133.05M | 114.58M | 63.84M | 36.86M |
| Net debt | 2122.31M | 1621.52M | 1413.12M | 96.33M | -598.33700M |
| Short term debt | 216.15M | 239.84M | 168.15M | 179.64M | 76.30M |
| Short long term debt | 179.25M | 207.38M | 143.20M | 117.67M | 53.61M |
| Short long term debt total | 2675.34M | 2714.60M | 2161.69M | 1141.37M | 344.87M |
| Other stockholder equity | 2066.05M | 2193.93M | 2316.82M | 2374.21M | 1949.16M |
| Property plant equipment | - | 1232.16M | 1083.49M | 679.46M | 413.60M |
| Total current assets | 1203.51M | 1637.66M | 1206.85M | 1405.50M | 1111.77M |
| Long term investments | 51.83M | 53.91M | 48.48M | 51.41M | 45.63M |
| Net tangible assets | - | -842.65300M | -952.68600M | 209.21M | 752.76M |
| Short term investments | - | - | - | - | 0.00000M |
| Net receivables | 590.19M | 480.64M | 403.93M | 323.34M | 131.92M |
| Long term debt | 1621.52M | 1737.70M | 1304.40M | 576.00M | 6.75M |
| Inventory | 1.38M | 12.19M | 11.83M | 7.51M | 3.93M |
| Accounts payable | 462.22M | 333.19M | 298.95M | 224.16M | 149.51M |
| Total permanent equity | - | - | - | - | 0.00000M |
| Noncontrolling interest in consolidated entity | - | - | - | - | 0.00000M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | 0.00000M |
| Accumulated other comprehensive income | 155.07M | - | - | - | 115.92M |
| Additional paid in capital | - | - | - | - | 0.00000M |
| Common stock total equity | - | - | - | 0.02M | 0.02M |
| Preferred stock total equity | - | - | - | - | 0.00000M |
| Retained earnings total equity | - | - | - | - | 0.00000M |
| Treasury stock | - | - | - | - | 0.00000M |
| Accumulated amortization | - | - | - | - | 0.00000M |
| Non currrent assets other | 117.35M | 234.32M | 180.31M | 76.09M | 19.32M |
| Deferred long term asset charges | - | - | - | - | 0.00000M |
| Non current assets total | 6380.98M | 5561.88M | 5240.55M | 3387.59M | 1800.69M |
| Capital lease obligations | 874.57M | 769.52M | 714.09M | 447.70M | 284.51M |
| Long term debt total | - | - | - | - | 268.57M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -591.46900M | -1274.05200M | -1042.76200M | -354.14900M | -262.38900M |
| Change to liabilities | 18.36M | 50.49M | 2.52M | 22.35M | 0.55M |
| Total cashflows from investing activities | -591.46900M | -1274.05200M | -1042.76200M | -354.14900M | -262.38900M |
| Net borrowings | 265.00M | 563.71M | 394.50M | -107.48900M | 68.38M |
| Total cash from financing activities | 92.94M | 364.68M | 756.42M | 921.43M | 218.84M |
| Change to operating activities | 7.39M | 1.33M | 9.99M | -12.16000M | -4.33300M |
| Net income | 428.43M | 273.46M | 335.05M | 186.94M | 98.72M |
| Change in cash | 344.52M | -296.48000M | 101.83M | 880.95M | 36.77M |
| Begin period cash flow | 748.56M | 1045.04M | 943.21M | 62.26M | 25.49M |
| End period cash flow | 1093.08M | 748.56M | 1045.04M | 943.21M | 62.26M |
| Total cash from operating activities | 843.90M | 630.87M | 371.51M | 299.22M | 80.32M |
| Issuance of capital stock | 0.00000M | 0.00000M | 389.17M | 992.78M | - |
| Depreciation | 206.22M | 154.22M | 108.74M | 73.15M | 9.08M |
| Other cashflows from investing activities | 6.75M | 8.80M | 8.81M | 9.13M | -19.40400M |
| Dividends paid | - | - | 12.98M | 38.00M | 38.00M |
| Change to inventory | -0.36300M | -3.72000M | -3.11000M | -0.23600M | -0.59300M |
| Change to account receivables | -129.16500M | -79.66500M | -164.28600M | -35.55600M | -28.19800M |
| Sale purchase of stock | -152.31700M | -213.72200M | - | 992.78M | 0.00000M |
| Other cashflows from financing activities | 477.15M | 824.23M | 577.80M | 43.53M | 225.44M |
| Change to netincome | 374.03M | 302.12M | 139.83M | 96.75M | 21.33M |
| Capital expenditures | 297.02M | 276.80M | 137.59M | 121.71M | 21.69M |
| Change receivables | - | - | - | 0.00000M | 0.00000M |
| Cash flows other operating | - | - | - | 0.00000M | 0.00000M |
| Exchange rate changes | - | - | - | 0.00000M | 0.00000M |
| Cash and cash equivalents changes | - | - | - | 0.00000M | 0.00000M |
| Change in working capital | -109.92300M | -48.79500M | -169.13900M | -24.59900M | -36.43900M |
| Stock based compensation | 31.27M | 43.38M | 32.61M | 18.11M | 2.16M |
| Other non cash items | 287.89M | 175.65M | 70.00M | 55.47M | 1.50M |
| Free cash flow | 546.88M | 354.07M | 233.92M | 177.51M | 58.63M |
Sector: Consumer Defensive Industry: Education & Training Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AFYA Afya Ltd |
0.55 3.77% | 15.13 | 15.12 | 9.26 | 0.47 | 2.13 | 3.47 | 8.65 |
| EDU New Oriental Education & Technology |
1.46 2.48% | 60.27 | 47.29 | 27.70 | 4.11 | 3.19 | 2.81 | 21.59 |
| TAL TAL Education Group |
-0.065 0.67% | 9.70 | - | 56.50 | 6.54 | 2.16 | 4.19 | -40.7835 |
| LOPE Grand Canyon Education Inc |
3.67 2.29% | 164.21 | 20.34 | 17.09 | 4.08 | 5.46 | 3.93 | 12.95 |
| IDPUF IDP Education Limited |
- -% | 8.35 | 42.72 | 34.01 | 4.36 | 12.36 | 3.87 | 14.16 |
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Alameda Oscar Niemeyer, No. 119, Nova Lima, MG, Brazil
| Name | Title | Year Born |
|---|---|---|
| Mr. Virgilio Deloy Capobianco Gibbon | Chief Exec. Officer | 1976 |
| Mr. Luis Andre Carpintero Blanco | Chief Financial Officer | 1973 |
| Renata Couto | Investor Relations Exec. Mang. | NA |
| Mr. Julio Eduardo Razente de Angeli | VP of Continuing Education & Innovation | 1973 |
| Mr. Virgilio Deloy Capobianco Gibbon | Chief Executive Officer | 1976 |
| Renata Couto | Investor Relations Executive Manager | NA |
| Mr. Julio Eduardo Razente de Angeli | Vice President of Continuing Education & Innovation | 1973 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
UK 
AU
CA
US
NZ
Please wait processing your request...